Skip to main content
Caplight Logo









SPARTA Biodiscovery

SPARTA Biodiscovery

Private
LondonHealthcare & Life Scienceshttps://spartabiodiscovery.com

Last Round

Seed

Sep 28, 2023

Total Funding Raised

$4.3M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

SPARTA Biodiscovery operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in September 2023.

SPARTA Biodiscovery is a life sciences and nanotechnology company that provides a nanoparticle analytical testing platform for the pharmaceutical and biotechnology industry.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

SPARTA Biodiscovery Comparables

Compare SPARTA Biodiscovery with similar companies based on industry and business-model similarity.

SPARTA Biodiscovery comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NanoFCM Inc.
80%
Spectradyne
75%
PANGEA Unternehmerkapital
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

SPARTA Biodiscovery Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 28, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Jelle Penders

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 21, 2026

    Grew 31% QoQ, from 16 to 21 employees.

  • Aug 20, 2026

    Monthly visitors grew 275% MoM, reaching 1.3K.

Book a demo to see all signals

For institutional investors. Book with your work email.

SPARTA Biodiscovery Filings

Explore SEC and related filing metadata, where available.

SPARTA Biodiscovery filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about SPARTA Biodiscovery's valuation, stock price, and market status.

Is SPARTA Biodiscovery a public or private company?

SPARTA Biodiscovery is a private company.

What is the current stock price of SPARTA Biodiscovery?

SPARTA Biodiscovery is a private company, so its shares have no public market price. Caplight tracks SPARTA Biodiscovery's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is SPARTA Biodiscovery worth (valuation)?

Valuation information for SPARTA Biodiscovery is not publicly available.

Can I buy SPARTA Biodiscovery stock?

SPARTA Biodiscovery shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was SPARTA Biodiscovery's last funding round?

SPARTA Biodiscovery's most recent funding round was Seed on September 28, 2023.

Who are the main investors in SPARTA Biodiscovery?

Investor information for SPARTA Biodiscovery is not publicly disclosed.

Will SPARTA Biodiscovery IPO soon?

No public IPO plans have been announced for SPARTA Biodiscovery.

How can I track SPARTA Biodiscovery secondary market activity?

Caplight tracks bids, offers, and trades in SPARTA Biodiscovery's shares on secondary markets.

Firmographic Details

HeadquartersLondon
Employee Range18
Year Founded2022
Last FundingSep 28, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?